Home PageMission StatementPartners in ExcellenceJoint VenturesExclusive Agent PartnersRegulatory & Technical ServicesRegulatory StrenghtRegulatory ServicesCustoms & LogisticsShanghai LabsFull Product LineOral ProductsInjectable ProductsVeterinary ProductsOncology ProductsInvestigational Stage ProductsProducts In DevelopmentLaboratory & DevelopmentR & D ServicesWhat's NewTrade Shows & SeminarsContact ChemwerthChemwerth China

 

 

 

 

A Full Service Active Pharmaceutical Ingredient Supplier

Complete Product List A - Z

A, B, C, D, E, F, G, H, I, J, K ,L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z


Items denoted by blue text have been approved in the USA/EC

** Pending Approval

ACAMPROSATE CALcIUM Apramycin SO4
Adapalene Argatroban
Amikacin SO4 USP AZACITIDINE
Amifostine USP AZELASTINE HYDROCHLORIDE
Amphotericin B USP AZTREONAM

BETAMETHASONE ACETATE Bivalirudin
BETAMETHASONE SODIUM PHOSPHATE BROMFENAC NA

Calcipotriene Clindamycin HCl USP/PhEur
Carboplatin USP Clindamycin PO4 USP
Carprofen Cyclosporine USP
Cisplatin USP

Dobutamine HCl USP DOXERCALCIFEROL
DOLASETRON MESYLATE  

Epirubicin HCl Ethosuximide USP
Esmolol HCl Etomidate
ESTRADIOL BENZOATE Etoposide USP

FENOLDOPAM MESYLATE Fosphenytoin Na USP
FIPRONIL FULVESTRANT
FLORFENICOL  

Gemcitabine HCl Granisetron HCl
Gold Sodium Thiomalate USP  

HYDROXYCHLOROQUINE SULFATE  

Ifosfamide USP Iron Sucrose USP**
IMIQUIMOD Isradipine USP
Inamrinone USP (Amrinone) Ivermectin (PF)
Irinotecan HCl 3H2O  

KETOTIFEN FUMARATE

Latanoprost Lovastatin USP
Lincomycin HCl USP  

Medroxyprogesterone Acetate USP Milrinone USP
Midodrine HCl (outside USA) Mitoxantrone HCl USP/PhEur

NAFTIFINE HCL NEPAFENAC
Nateglinide NESIRITIDE
Neomycin Sulfate USP Nisoldipine**

Ondansetron USP** OXALIPLATIN

Pamidronic Acid procarbazine hcl

Ropivacaine HCl H2O USP  

Sirolimus**  

Tacrolimus Tobramycin USP/PhEur
TESTOSTERONE PROPIONATE Topiramate**
tiagabine hydrochloride TOPOTECAN HCL
Tizanidine HCl USP  

Vecuronium Br USP Vinorelbine Tartrate USP

ZOLEDRONIC ACID  

Patented products available for research and development use
as permitted under CFR 35 section